In Depth
‘Nothing matters as long as the price is cheaper’
To everything there is a season, the AJP wrote in 1964 – as the season of weighing up professional quality against price came around again W.R.Cutler wrote a guest editorial …
April MIMS update
We look at some of the recent changes to the medicines landscape, with new products, indications and contraindications New Products Fezolinetant (Veoza) is a nonhormonal selective NK3 receptor antagonist that …
Investment ratings houses cool on Sigma/CWH deal
Evidence is growing that some institutional advisors may be starting to grow wary of the CWH/Sigma deal, says Mike Taylor When financial advisers make investment recommendations to clients they are …
Research Roundup
Debbie Rigby rounds up the latest in research news Treatment of chronic insomnia in adults Despite guidelines recommending nonpharmacologic methods as the primary strategy to treat chronic insomnia, medications are …
Improving your patient engagement and experience
Transformational vs transactional : how would your customers describe their visit to your pharmacy? Glenn Guilfoyle and Marta Stybowski break down the steps to ensuring a better patient experience One …
Ozempic isn’t approved for weight loss in Australia. So how are people accessing it?
Hundreds of thousands of people worldwide are taking drugs like Ozempic to lose weight. But what do we actually know about them? The Conversation’s experts, Andrew Bartlett, Jessica Pace and …
Whither pharmacy?
Pharmacists need to highlight the value they offer as greedy grocers snatch front-of-shop sales It’s April 1934, and GG Jewkes, the vice president of the Federated Pharmaceutical Service Guild of …
Research Roundup
Debbie Rigby rounds up the latest in research news Prevalence and patterns of comorbidities in older people with type 2 diabetes in Australian primary care settings This study used BEACH …
Price pressures
What are the 5 key forces at play in the current pharmacy market? Natalie Sirianni explains The last 5 years Over the last five or so years, we have seen …
Cardiovascular risks and Covid-19
New research confirms the benefits of vaccination, writes Glen Pyle, Dalhousie University Covid-19 is a respiratory disease. Yet, from the earliest days of the pandemic, the cardiovascular risks associated with …
Research Roundup
Debbie Rigby rounds up the latest in research news Blood pressure and variability responses to the down-titration of antihypertensive drugs In this study, down-titration of antihypertensive drugs in people with …
Regulatory barriers may not be enough to stop CWH, Sigma merger
Sigma Healthcare’s merger with Chemist Warehouse may go ahead despite competition concerns Associate Professor of Finance at RMIT, Angel Zhong, warns Corporate Australia loves a big merger. And amid a growing …